Capital Fund Management (CFM)
AZN icon

Capital Fund Management (CFM)’s AstraZeneca AZN Stock Holding History

Capital Fund Management (CFM)’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-34,150
Closed -$6.74M – 2080
2026
Q1 		$6.74M Buy
34,150
+24,800
+265% +$4.78M 0.03% 752
2025
Q4 		$1.72M Sell
9,350
-6,150
-40% -$1.08M ﹤0.01% 1777
2025
Q3 		$2.38M Buy
+15,500
New +$2.35M 0.01% 1696
2025
Q2 		– Sell
-13,950
Closed -$2.05M – 2334
2025
Q1 		$2.05M Sell
13,950
-800
-5% -$116K 0.01% 1410
2024
Q4 		$1.93M Buy
14,750
+8,350
+130% +$1.17M ﹤0.01% 1501
2024
Q3 		$997K Buy
+6,400
New +$1.03M ﹤0.01% 1685
2023
Q4 		– Sell
-7,600
Closed -$1.03M – 2099
2023
Q3 		$1.03M Sell
7,600
-1,900
-20% -$260K ﹤0.01% 1631
2023
Q2 		$1.36M Sell
9,500
-9,900
-51% -$1.46M 0.01% 1309
2023
Q1 		$2.69M Sell
19,400
-9,350
-33% -$1.26M 0.01% 963
2022
Q4 		$3.9M Sell
28,750
-2,800
-9% -$351K 0.03% 707
2022
Q3 		$3.46M Sell
31,550
-2,850
-8% -$362K 0.03% 674
2022
Q2 		$4.55M Buy
+34,400
New +$4.51M 0.04% 537
2020
Q1 		– Sell
-2,900
Closed -$289K – 1553
2019
Q4 		$289K Buy
+2,900
New +$273K ﹤0.01% 1613
2015
Q1 		– Sell
-11,900
Closed -$838K – 1427
2014
Q4 		$838K Sell
11,900
-5,100
-30% -$365K 0.01% 945
2014
Q3 		$1.21M Sell
17,000
-28,800
-63% -$2.11M 0.01% 857
2014
Q2 		$3.4M Buy
45,800
+500
+1% +$36.1K 0.04% 544
2014
Q1 		$2.94M Buy
45,300
+15,200
+50% +$982K 0.04% 530
2013
Q4 		$1.79M Buy
30,100
+12,700
+73% +$690K 0.02% 740
2013
Q3 		$904K Buy
+17,400
New +$874K 0.01% 919

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Fund Management (CFM)'s AZN Position: Q2 2026 in Review

Capital Fund Management (CFM) sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 51,161 shares — an estimated $10.1M sold.

Capital Fund Management (CFM) first reported a position in AZN in Q2 2013 and held it in 22 quarters. The position peaked at $40.3M in Q4 2023. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Capital Fund Management (CFM) reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 51,161 AstraZeneca shares in Q2 2026, an estimated $10.1M.
  • Capital Fund Management (CFM) first reported a position in AstraZeneca in Q2 2013 and held it in 22 quarters.
  • Capital Fund Management (CFM)'s AstraZeneca position peaked at $40.3M in Q4 2023.
  • 1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.